Pharmaceutical CEOs are on notice about sky-high drug prices as President Donald Trump demands a recalibration of what Americans are paying compared to other countries.

Shares in Asia are mostly higher after the U.S. and China ended their latest round of trade talks without a deal. U.S, ...

In most cases, it will take years for them to rebuild. LA issued its first building permit nearly two months after the fires started. It took more than seven months before the first building permit ...

Net revenue1 of 1,346 million euros, up 2.9%, sustained by organic growth of +2.3% Acceleration in organic growth during the second quarter of ...

INBRAIN Neuroelectronics has announced promising interim results from the world's first human clinical study of its graphene-based brain-computer interface (BCI), marking a major leap forward in ...

Also in today’s newsletter, EU warns Europe’s roads unfit for war, UBS currency derivatives and Botswana’s push on De Beers ...

India], July 28: Merck Foundation, the philanthropic arm of Merck KGaA Germany, marks ‘World ART (Assisted Reproductive ...

The deal, which focuses first on a COPD drug GSK believes holds “best-in-class” potential, could involve a dozen medicines ...

Poster presentation of updated data on BT-001 from the Phase 1 part of the ongoing Phase 1/2a study in solid tumors - LUND, SE / ACCESS Newswire / July 28, 2025 / BioInvent International AB ("BioInven ...

The ongoing Phase I/IIa study (NCT04725331) is a multicenter, open label, dose-escalation study evaluating BT-001 as a single agent and in combination with MSD’s (Merck & Co., Inc., Rahway, NJ, USA) ...

Also on Trump’s mind is the Federal Reserve. Its chair Jay Powell will on Wednesday unveil the US central bank’s decision on interest rates. The uncomfortable relationship between the president and ...

The 10th annual conference featured sessions on leadership, becoming invaluable at work and developing a legacy through community.